基于我的深度文献检索，我现在整理出关于STAT6蛋白结构域特征及其在过敏性疾病中作用机制的结构化报告：

----
id: "sharma2023_gof_stat6"
title: "Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease"
authors: ["M Sharma", "S Baris", "N Suratannon", "et al"]
year: 2023
journal: "Journal of Experimental Medicine"
doi: "10.1084/jem.20221755"
citation_key: "sharma2023"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC10037107/"
content: |
  This study identifies heterozygous gain-of-function (GOF) variants in STAT6 as a novel autosomal dominant allergic disorder. The STAT6 protein contains several key structural domains where GOF mutations are located: DNA-binding domain (variants p.E382, p.D419), linker domain (variant p.D519), SH2 domain (variant p.K595), and transactivation domain near phosphorylation site (variant p.P643). These mutations enhance STAT6 activity through multiple mechanisms: enhanced DNA binding due to decreased electro-negativity near DNA-binding interface, sustained phosphorylation with slower dephosphorylation kinetics, increased transcriptional activity for STAT6 target genes, TH2 cell skewing with increased production of TH2 cytokines (IL-4, IL-5, IL-13), and upregulation of key receptors (IL-4Rα, CD23) creating a feedback loop that amplifies allergic signaling.

----
id: "baris2023_stat6_dbd"
title: "Severe Allergic Dysregulation Due to A Gain of Function Mutation in the Transcription Factor STAT6"
authors: ["S Baris", "M Sharma", "et al"]
year: 2023
journal: "Journal of Allergy and Clinical Immunology"
doi: "10.1016/j.jaci.2023.02.032"
citation_key: "baris2023"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC10330134/"
content: |
  This study reports a child with a missense mutation in the DNA binding domain of STAT6 (c.1114G>A, p.E372K) who presented with severe atopic dermatitis, eosinophilia, elevated IgE, and food allergies. The DNA binding domain is responsible for the transcription factor's ability to bind to specific DNA sequences and activate target gene expression. The gain-of-function mutation leads to enhanced STAT6 phosphorylation and nuclear translocation in response to IL-4/IL-13 signaling, increased T helper 2 (TH2) cell responses, skewing of regulatory T cells (Tregs) to a TH2-like phenotype, and augmented B cell class switching to IgE. These dysregulated functions collectively result in severe allergic manifestations by promoting type 2 immunity.

----
id: "krishnamurthy2016_stat6_domains"
title: "STAT6 and PARP Family Members in the Development of T Cell-dependent Allergic Inflammation"
authors: ["P Krishnamurthy", "JY Lee", "et al"]
year: 2016
journal: "Immune Network"
doi: "10.4110/in.2016.16.4.201"
citation_key: "krishnamurthy2016"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC5002446/"
content: |
  The protein structure and domain organization of STAT6 includes: N-terminal domain (involved in dimerization), coiled-coil domain (required for interaction with other proteins), DNA binding domain (binds to specific DNA sequences), SH2 domain (src homology 2 domain, interacts with phosphorylated tyrosine residues on cytokine receptor IL-4Rα), and transactivation domain (located at C-terminal end). STAT6 is activated by cytokines IL-4 and IL-13, where STAT6 monomers are recruited to the receptor, phosphorylated by JAK kinases, and dimerize via their SH2 domains. The STAT6 dimer translocates to the nucleus and binds to specific DNA sequences (TTCN₄GAA) to activate transcription of genes involved in allergic responses, including Th2 cell differentiation, IgE class switching, chemokine production (eotaxin-3/CCL26), and regulation of epithelial barrier function.

----
id: "chen2023_stat6_club"
title: "STAT6 joins the gain-of-function club"
authors: ["K Chen", "T Chatila"]
year: 2023
journal: "Journal of Allergy and Clinical Immunology"
doi: "10.1016/j.jaci.2023.04.006"
citation_key: "chen2023"
url: "https://www.jacionline.org/article/S0091-6749(23)00593-6/fulltext"
content: |
  This commentary discusses the mechanisms of allergy/immunology related to severe allergic dysregulation due to gain-of-function mutations in the transcription factor STAT6. The SH2 domain of STAT6 serves dual purposes: providing a docking domain for binding to phosphorylated tyrosine residues on cytokine receptors and facilitating STAT6 dimerization after phosphorylation. Gain-of-function mutations in STAT6 domains lead to spontaneous activation of the STAT6 signaling pathway, resulting in early-onset and severe allergic inflammation through dysregulated type 2 immune responses.

----
id: "daniel2000_stat6_sh2"
title: "A Gain-of-function Mutation in STAT6"
authors: ["C Daniel", "R Salvekar", "U Schindler"]
year: 2000
journal: "Journal of Biological Chemistry"
doi: "10.1074/jbc.275.19.14255"
citation_key: "daniel2000"
url: "https://pubmed.ncbi.nlm.nih.gov/10747856/"
content: |
  This study identified two amino acids in the STAT6 SH2 domain that, when mutated, uncouple the activity of the STAT6 protein from its regulatory cytokine, IL-4. The STAT6VT mutant carries two amino acid changes in the SH2 domain that affect the overall structure and stability of the monomeric and dimeric protein. The SH2 domain mutations result in constitutive STAT6 activation independent of cytokine stimulation, demonstrating the critical role of the SH2 domain in maintaining proper STAT6 regulation and preventing aberrant allergic responses.

----
id: "litterst2002_stat6_tad"
title: "An LXXLL Motif in the Transactivation Domain of STAT6 Mediates Recruitment of NCoA-1/SRC-1"
authors: ["CM Litterst", "E Kliem", "et al"]
year: 2002
journal: "Journal of Biological Chemistry"
doi: "10.1074/jbc.M201831200"
citation_key: "litterst2002"
url: "https://www.jbc.org/article/S0021-9258(18)36571-2/fulltext"
content: |
  This study identifies an LXXLL motif in the transactivation domain of STAT6 that mediates recruitment of nuclear receptor coactivators NCoA-1/SRC-1. The transactivation domain, located at the C-terminal end of STAT6, contains this conserved motif that is essential for the transcriptional activity of STAT6. The LXXLL motif facilitates interaction with coactivator proteins, enhancing STAT6-mediated gene transcription in allergic responses. This structural feature in the transactivation domain is crucial for the full transcriptional potential of STAT6 in promoting type 2 immune responses and allergic inflammation.

----
id: "mandal2015_sh2_targeting"
title: "Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 6 (STAT6) with Small Molecules"
authors: ["PK Mandal", "W Gao", "et al"]
year: 2015
journal: "Journal of Medicinal Chemistry"
doi: "10.1021/acs.jmedchem.5b01265"
citation_key: "mandal2015"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC5109833/"
content: |
  This study focuses on developing small molecule inhibitors targeting the SH2 domain of STAT6 for allergic airway disease treatment. The SH2 domain is the most functional domain of STAT6, serving two critical purposes: providing a docking domain for binding to phosphorylated tyrosine residues on cytokine receptors and facilitating STAT6 dimerization after phosphorylation. Small molecules that disrupt SH2 domain function can inhibit STAT6 activation, dimerization, and nuclear translocation, thereby blocking the transcription of genes involved in allergic inflammation, including those regulating eosinophil recruitment, IgE production, and airway hyperresponsiveness.

----
id: "zhou2012_stat6_phosphorylation"
title: "STAT6 phosphorylation inhibitors block eotaxin-3 secretion in bronchial epithelial cells"
authors: ["L Zhou", "H Ohkawara", "et al"]
year: 2012
journal: "Bioorganic & Medicinal Chemistry Letters"
doi: "10.1016/j.bmcl.2011.11.029"
citation_key: "zhou2012"
url: "https://www.sciencedirect.com/science/article/pii/S0968089611010121"
content: |
  This study demonstrates that following binding to receptor phosphotyrosines by its SH2 domain, STAT6 becomes phosphorylated at conserved tyrosine residue Y641 and subsequently dimerizes. The phosphorylation at Y641 is essential for STAT6 activation and function in allergic responses. Inhibitors targeting STAT6 phosphorylation can effectively block the secretion of eotaxin-3 (CCL26), a key chemokine involved in eosinophil recruitment in allergic diseases like asthma. This highlights the importance of the phosphorylation mechanism in STAT6-mediated allergic inflammation.

----
id: "knight2018_stat5_6_sh2"
title: "Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease"
authors: ["JM Knight", "L Davidson", "et al"]
year: 2018
journal: "Journal of Biological Chemistry"
doi: "10.1074/jbc.RA118.002097"
citation_key: "knight2018"
url: "https://www.jbc.org/article/S0021-9258(20)33844-8/fulltext"
content: |
  This research demonstrates that small molecule inhibitors targeting the SH2 domains of STAT5 and STAT6 can effectively inhibit allergic airway disease. The SH2 domain is critical for STAT6 function as it mediates both receptor binding and dimerization. By disrupting SH2 domain interactions, these inhibitors prevent STAT6 activation and subsequent transcriptional activity, thereby reducing allergic inflammation markers including eosinophil infiltration, mucus production, and airway hyperresponsiveness in experimental models of asthma.

----
id: "goenka2011_stat6_review"
title: "Transcriptional regulation by STAT6"
authors: ["S Goenka", "MH Kaplan"]
year: 2011
journal: "Immunologic Research"
doi: "10.1007/s12026-011-8206-1"
citation_key: "goenka2011"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC3107597/"
content: |
  This comprehensive review details the domain organization and transcriptional regulation mechanisms of STAT6. The protein contains distinct functional domains: N-terminal domain for dimer-dimer interactions, coiled-coil domain for protein interactions, DNA-binding domain for sequence-specific DNA recognition, SH2 domain for phosphotyrosine binding and dimerization, and C-terminal transactivation domain for coactivator recruitment. In dendritic cells, STAT6 regulates IL-10 and IL-12 production, influencing Th1/Th2 balance. The structural domains work in concert to mediate STAT6's role in allergic inflammation through coordinated activation, dimerization, nuclear translocation, and gene transcription processes.

----